Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study
Journal of Clinical Medicine · 19.06.2023 · 12 (12) · 4126
DOI: 10.3390/jcm12124126 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.06.2023. Verfasst von Xiaoli Mu und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Backgrounds: Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rarely high-grade neuroendocrine carcinoma of the lung with features of both small cell and non-small cell lung cancer. In this study, we aim to construct a prognostic nomogram that integrates the clinical features and treatment options to predict disease-specific survival (DSS).
Methods
A total of 713 patients diagnosed with LCNEC were from the US National Cancer Institute’s Surveillance Epidemiology and End Results (SEER) registry between 2010–2016. Cox proportional hazards analysis was conducted to choose the significant predictors of DSS. External validation was performed using 77 patients with LCNEC in the West China Hospital Sichuan University between 2010–2018. The predictive accuracy and discriminative capability were estimated by the concordance index (C-index), calibration curve, and receiver operating characteristic (ROC) curve. The clinical applicability of the nomogram was verified through the decision curve analysis (DCA). Additionally, we conducted a subgroup analysis of data available in the external cohort that may impact prognosis but was not recorded in the SEER database.
Results
Six independent risk factors for DSS were identified and integrated into the nomogram. The nomogram achieved good C- indexes of 0.803 and 0.767 in the training and validation group, respectively. Moreover, the calibration curves for the probability of survival showed good agreement between prediction by nomogram and actual observation in 1-, 3- and 5-year DSS. The ROC curves demonstrated the prediction accuracy of the established nomogram (all Area Under Curve (AUC) > 0.8). DCA exhibited the favorable clinical applicability of the nomogram in the prediction of LCNEC survival. A risk classification system was built which could perfectly classify LCNEC patients into high-, medium- and low-risk groups (p < 0.001). The survival analysis conducted on the West China Hospital cohort indicated that whole brain radiation therapy (WBRT), prophylactic cranial irradiation (PCI), surgical procedures, tumor grade, Ki-67, and PD-L1 expression were not significantly associated with DSS.
Conclusion
This study has effectively developed a prognostic nomogram and a corresponding risk stratification system, which demonstrate promising potential for predicting the DSS of patients with LCNEC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
- Lung Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
- Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Zitieren
APA
Mu, X., Pu, D., Zhu, Y., Zhou, Y., Wu, Q., Liu, Q., Yin, L., & Li, Y. (2023). Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study. Journal of Clinical Medicine, 12(12), 4126. https://doi.org/10.3390/jcm12124126
Vancouver
Mu X, Pu D, Zhu Y, Zhou Y, Wu Q, Liu Q, et al. Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study. Journal of Clinical Medicine. 2023;12(12):4126. doi:10.3390/jcm12124126
BibTeX
@article{Mu2023,
author = {Mu, Xiaoli and Pu, Dan and Zhu, Yajuan and Zhou, Yixin and Wu, Qiang and Liu, Qing and Yin, Liyuan and Li, Yan},
title = {Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {12},
pages = {4126},
doi = {10.3390/jcm12124126}
}
EUVIMED